Combined yeast-derived i-glucan with anti-tumor monoclonal antibody for cancer immunotherapy
Revision as of 07:26, 9 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == Combined yeast-derived i-glucan with anti-tumor monoclonal antibody for cancer immunotherapy; J Liu, L Gunn, Hansen, J Yan; 2009; doi_citing_unknown == Retraction == Retracted: Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer; Zeng, Yuanfeng; Xie, Huijun; Qiao, Yudan; Wang, Jianmei; Zhu, Xiling; He, Guoyang; Li, Yuling; Ren, ; 2015-10-01 ; https://doi.org/10.1111/cas.12768 == Citation piece ==...")
Target ArticleEdit
Combined yeast-derived i-glucan with anti-tumor monoclonal antibody for cancer immunotherapy; J Liu, L Gunn, Hansen, J Yan; 2009; doi_citing_unknown
RetractionEdit
Retracted: Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer; Zeng, Yuanfeng; Xie, Huijun; Qiao, Yudan; Wang, Jianmei; Zhu, Xiling; He, Guoyang; Li, Yuling; Ren, ; 2015-10-01
Citation pieceEdit
Note: Open to append information.